Rat Bite Treatment and Dosage
For rat bites, administer amoxicillin-clavulanate 875/125 mg twice daily orally for prophylaxis in high-risk patients, ensure tetanus prophylaxis (Tdap preferred if not previously given within 10 years), and evaluate for rabies post-exposure prophylaxis based on local epidemiology, though rabies prophylaxis is typically not required for rat bites in most settings. 1
Wound Management
Immediate wound care is the cornerstone of treatment:
- Copious irrigation of the wound
- Cautious debridement of devitalized tissue
- Avoid primary closure except for facial wounds, which may be approximated after thorough irrigation and debridement 1
The deep puncturing nature of rodent bites creates an environment conducive to infection, though the natural infection rate without prophylaxis is surprisingly low at approximately 2% 2.
Antibiotic Prophylaxis
When to Use Prophylaxis
Preemptive antibiotic therapy for 3-5 days is recommended for patients who are: 1
- Immunocompromised
- Asplenic
- Have advanced liver disease
- Have preexisting or resultant edema of the affected area
- Have moderate to severe injuries, especially to the hand or face
- Have injuries that may have penetrated the periosteum or joint capsule
Antibiotic Selection and Dosing
First-line: Amoxicillin-clavulanate 875/125 mg orally twice daily 1
This combination provides coverage for the polymicrobial nature of rat bite infections, which commonly include Staphylococcus aureus (the most common isolate), along with various aerobic and anaerobic Gram-positive and Gram-negative bacteria 3.
Alternative oral regimens include: 1
- Doxycycline 100 mg twice daily (good activity against common pathogens; some streptococci resistant)
- Sulfamethoxazole-trimethoprim 160-800 mg twice daily (good aerobic coverage; poor anaerobic activity)
- Moxifloxacin 400 mg daily (monotherapy option with anaerobic coverage)
For established infections requiring IV therapy: 1
- Ampicillin-sulbactam 1.5-3.0 g every 6-8 hours IV
- Piperacillin-tazobactam 3.37 g every 6-8 hours IV
Duration
7-10 days for prophylaxis or treatment of established infection 1
Tetanus Prophylaxis
Tetanus toxoid must be administered to patients without toxoid vaccination within 10 years. 1
- Tdap (tetanus, diphtheria, pertussis) is preferred over Td if not previously given 1
- This is mandatory as most rat bite patients are deficient in tetanus immunity 2
Rabies Post-Exposure Prophylaxis
Consultation with local health officials is recommended to determine if rabies vaccination should be initiated. 1
In most settings, rabies prophylaxis is usually not required for rat bites as rats are not significant rabies vectors 2. However, if indicated based on local epidemiology:
For Previously Unvaccinated Patients:
Reduced 4-dose vaccine schedule: 4, 5, 6
- Human diploid cell vaccine (HDCV) or purified chick embryo cell vaccine (PCECV)
- 1 mL intramuscularly on days 0,3,7, and 14
- Plus rabies immunoglobulin (RIG) infiltrated into and around the wound
For Previously Vaccinated Patients:
2-dose series on days 0 and 3 (no RIG needed) 4
For Immunocompromised Patients:
5-dose series remains unchanged (days 0,3,7,14, and 28) with RIG 4
Common Pitfalls to Avoid
- Over-prescribing antibiotics: The natural infection rate is only 2% without prophylaxis 2, so reserve antibiotics for high-risk patients
- Wrong antibiotic selection: Avoid narrow-spectrum agents like cephalexin or dicloxacillin alone, as 72.5% of rat bite infections are polymicrobial 3
- Primary closure of wounds: This increases infection risk; facial wounds are the exception 1
- Forgetting tetanus: This is mandatory and often overlooked 2
- Unnecessary rabies prophylaxis: Rats are not significant rabies vectors in most regions; consult local health authorities 1, 2
Bacterial Considerations
Rat bite wounds harbor approximately 22 different bacterial species across 18 genera 3. While Staphylococcus aureus is most common, the majority of infections are polymicrobial, necessitating broad-spectrum coverage when antibiotics are indicated. Common isolates include S. epidermidis (43% in one study), Bacillus subtilis, diphtheroids, and alpha-hemolytic Streptococcus 2.